Genetics providers' experiences using telehealth: A grounded theory approach.

genetic counseling genetics services healthcare providers telehealth telemedicine

Journal

Journal of genetic counseling
ISSN: 1573-3599
Titre abrégé: J Genet Couns
Pays: United States
ID NLM: 9206865

Informations de publication

Date de publication:
10 2022
Historique:
revised: 18 04 2022
received: 06 06 2021
accepted: 24 04 2022
pubmed: 6 5 2022
medline: 5 10 2022
entrez: 5 5 2022
Statut: ppublish

Résumé

There was a paucity of research describing the perspectives and experiences of clinical genetics providers in telehealth prior to the SARS-CoV-2 pandemic. The available literature focused primarily on provider satisfaction and offered limited insight into genetics providers' work in telehealth. The purpose of this study, conducted just prior to the widespread knowledge of SARS-CoV-2 in the United States and mass transition to telehealth, was to understand the telehealth process from the vantage of genetics providers working in telehealth practice settings. This research employed grounded theory using the constant comparative method in coding and analysis of data to generate theory. Ten genetics providers were interviewed over the phone about their experiences, specifically the efficacy of telehealth work, providers' perspectives of patient outcomes, and personal fulfillment derived from telehealth patient care. Six themes emerged in the study: Making Professional Choices, Increasing Patient Access, Providing Effective Services, Understanding Telehealth Limits, Feelings about Telehealth Consultations, and Deepening Personal Fulfillment. These major themes guided the creation of the Theoretical Model of Telehealth Providers in Genetics, which depicts the connections between providers' personal fulfillment in telehealth, commitment to patient services, and the provision of telehealth to the public. This model may help others who are working on telehealth initiatives or developing telehealth programs. Findings from this study can support the current use and the growth of telehealth in genetics as a result of the SARS-CoV-2 pandemic. Future research is needed to describe the telehealth process and develop valid instruments for assessing and measuring the constructs of the Theoretical Model of Telehealth Providers in Genetics.

Identifiants

pubmed: 35510371
doi: 10.1002/jgc4.1586
pmc: PMC9790448
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1155-1163

Informations de copyright

© 2022 The Authors. Journal of Genetic Counseling published by Wiley Periodicals LLC on behalf of National Society of Genetic Counselors.

Références

Stroke. 2017 Jan;48(1):e3-e25
pubmed: 27811332
J Genet Couns. 2021 Oct;30(5):1233-1243
pubmed: 34617357
Telemed J E Health. 2018 Feb;24(2):130-138
pubmed: 28737998
Telemed J E Health. 2010 Apr;16(3):350-7
pubmed: 20406122
J Am Board Fam Med. 2017 May-Jun;30(3):320-330
pubmed: 28484064
Pediatrics. 2015 Jul;136(1):202-9
pubmed: 26122802
J Perinatol. 2022 Feb;42(2):262-268
pubmed: 34302053
J Genet Couns. 2021 Oct;30(5):1214-1223
pubmed: 34757671
Appl Clin Inform. 2010 May 05;1(2):132-41
pubmed: 23616832
Arq Bras Cardiol. 2019 Nov;113(5):1006-1056
pubmed: 31800728
Health Care Manag (Frederick). 2019 Jul/Sep;38(3):239-246
pubmed: 31261191
Eur J Hum Genet. 2016 Aug;24(9):1255-61
pubmed: 26785833
J Genet Couns. 2021 Aug;30(4):989-998
pubmed: 34308554
J Genet Couns. 2018 Apr;27(2):329-338
pubmed: 29362948
J Emerg Med. 2017 Dec;53(6):924-925
pubmed: 29102096
J Genet Couns. 2016 Apr;25(2):337-43
pubmed: 26283062
J Genet Couns. 2021 Aug;30(4):999-1009
pubmed: 34231953
J Am Assoc Nurse Pract. 2020 Mar;32(3):190-192
pubmed: 32132456
Genet Med. 2020 Jan;22(1):227-231
pubmed: 31417191
Genet Med. 2019 Aug;21(8):1874-1877
pubmed: 30686822
Trials. 2014 Sep 17;15:361
pubmed: 25227174
J Genet Couns. 2018 Apr;27(2):339-348
pubmed: 29243007
J Genet Couns. 2022 Oct;31(5):1155-1163
pubmed: 35510371
J Genet Couns. 2020 Oct;29(5):771-785
pubmed: 31876018
Genet Med. 2012 Sep;14(9):765-76
pubmed: 23393646
Am J Hum Genet. 2019 Jan 3;104(1):13-20
pubmed: 30609404
Am J Manag Care. 2019 Jan;25(1):40-44
pubmed: 30667610
J Genet Couns. 2021 Feb;30(1):7-10
pubmed: 33191601
J Med Syst. 2017 Feb;41(2):21
pubmed: 27987158
J Genet Couns. 2021 Oct;30(5):1361-1378
pubmed: 34355839

Auteurs

Lauren A Beretich (LA)

Healthcare Genetics, School of Nursing, Clemson University, Clemson, South Carolina, USA.

Sara M Sarasua (SM)

Healthcare Genetics, School of Nursing, Clemson University, Clemson, South Carolina, USA.

Jane M DeLuca (JM)

Healthcare Genetics, School of Nursing, Clemson University, Clemson, South Carolina, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH